-
GlobalData: Big tobacco may manufacture next flu shot
LONDON - A new tobacco-based seasonal influenza vaccine being developed by Mitsubishi Tanabe Pharma and currently in Phase III studies could potentially rival traditional chicken egg-based vaccines, as it aims to launch in the U.S. for the 2018-19 flu season, according to an analyst with research and consulting firm GlobalData.Avalere: Rising coinsurance means less certainty on cost for Medicare PDP beneficiaries
WASHINGTON — Medicare Part D plan (PDP) beneficiaries might be paying more out of pocket for a majority of their prescription medication, according to a new analysis from Avalere Health. The company found that a majority — 58% of covered drugs among PDPs — of medications are subject to coinsurance rather than copayments for beneficiaries. In 2014, only about 35% of covered drugs were subject to coinsurance.